William Richard White Akero Therapeutics, Inc. (AKRO) insider trading activity

William Richard White is Chief Financial Officer of Akero Therapeutics, Inc.. Currently has a direct ownership of 46,799 shares of AKRO, which is worth approximately $1.04 Million. The most recent transaction as insider was on Nov 01, 2021, when has been sold 6,500 shares (Common Stock) at a price of $22.24 per share, resulting in proceeds of $144,560. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 46.8K

5.7% 3M change

145.02% 12M change

Total Value Held $1.04 Million

William Richard White Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 01 2021	SELL Open market or private sale	$144,560 $22.24 p/Share	6,500 Reduced 66.48%	3,277 Common Stock
Nov 01 2021	BUY Exercise of conversion of derivative security	$45,565 $7.01 p/Share	6,500 Added 39.93%	9,777 Common Stock
Oct 01 2021	SELL Open market or private sale	$143,390 $22.06 p/Share	6,500 Reduced 66.48%	3,277 Common Stock
Oct 01 2021	BUY Exercise of conversion of derivative security	$45,565 $7.01 p/Share	6,500 Added 39.93%	9,777 Common Stock
Sep 01 2021	SELL Open market or private sale	$205,416 $24.0 p/Share	8,559 Reduced 72.31%	3,277 Common Stock
Sep 01 2021	BUY Exercise of conversion of derivative security	$59,999 $7.01 p/Share	8,559 Added 41.97%	11,836 Common Stock
Aug 02 2021	SELL Open market or private sale	$97,835 $22.03 p/Share	4,441 Reduced 57.54%	3,277 Common Stock

Aug 02 2021	BUY Exercise of conversion of derivative security	$31,131 $7.01 p/Share	4,441 Added 36.52%	7,718 Common Stock
Jul 06 2021	SELL Open market or private sale	$159,380 $24.52 p/Share	6,500 Reduced 66.48%	3,277 Common Stock
Jul 06 2021	BUY Exercise of conversion of derivative security	$45,565 $7.01 p/Share	6,500 Added 39.93%	9,777 Common Stock
May 03 2021	SELL Open market or private sale	$128,352 $30.56 p/Share	4,200 Reduced 64.91%	2,270 Common Stock
May 03 2021	BUY Exercise of conversion of derivative security	$29,442 $7.01 p/Share	4,200 Added 39.36%	6,470 Common Stock
Apr 01 2021	SELL Open market or private sale	$1,448,000 $28.96 p/Share	50,000 Reduced 95.66%	2,270 Common Stock
Apr 01 2021	BUY Exercise of conversion of derivative security	$350,500 $7.01 p/Share	50,000 Added 48.89%	52,270 Common Stock
Jun 30 2020	BUY Grant, award, or other acquisition	$21,252 $17.07 p/Share	1,245 Added 35.42%	2,270 Common Stock

Also insider at

VTYX

Ventyx Biosciences, Inc. Healthcare

GMTX

Gemini Therapeutics, Inc. Healthcare

WRW